Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-281
Closed -$90.5K 88
2024
Q3
$90.5K Hold
281
0.02% 138
2024
Q2
$87.8K Buy
+281
New +$82.6K 0.02% 139
2020
Q3
Sell
-29
Closed -$6.84K 47
2020
Q2
$6.84K Buy
+29
New +$6.62K ﹤0.01% 183
2020
Q1
Sell
-5,054
Closed -$1.2M 48
2019
Q4
$1.2M Buy
5,054
+129
+3% +$28.4K 0.87% 19
2019
Q3
$953K Buy
4,925
+100
+2% +$19.2K 0.78% 21
2019
Q2
$889K Buy
4,825
+1,381
+40% +$247K 0.67% 24
2019
Q1
$650K Buy
+3,444
New +$658K 0.43% 37

Other funds holding AMGN

MFA Wealth Advisors's AMGN Position: Q4 2024 in Review

MFA Wealth Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 281 shares — an estimated $90.5K sold.

MFA Wealth Advisors first reported a position in AMGN in Q1 2019 and held it in 7 quarters. The position peaked at $1.2M in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • MFA Wealth Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • MFA Wealth Advisors sold 281 Amgen shares in Q4 2024, an estimated $90.5K.
  • MFA Wealth Advisors first reported a position in Amgen in Q1 2019 and held it in 7 quarters.
  • MFA Wealth Advisors's Amgen position peaked at $1.2M in Q4 2019.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on MFA Wealth Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.